Hebrew University professor Uriel Bachrach to be honored in Rome

November 30, 2010

Jerusalem, November 29, 2010 - Prof. Emeritus Uriel Bachrach of the Hebrew University of Jerusalem will receive a special award from the mayor of Rome on Wednesday, Dec. 1, in Rome. The award is being given to four distinguished scientists from Japan, the US and Israel who have made significant contributions to cancer research.

A press conference featuring the scientists will also be held in connection with at the occasion.

Prof. Bachrach is one of the organizers of the 11th International Conference on Polyamine, Cancer and Other Diseases, being held this week in Tivoli, Italy.

Prof. Bachrach, who served for more than 60 years as a professor of microbiology at the Hebrew University Faculty of Medicine from its inception, was born in Germany 1926 and emigrated to Israel, where he earned his Ph.D. at the Hebrew University. He served during his career also as a visiting professor or scientist at universities in the US, Italy and Ethiopia and received an honorary doctorate at the University of Bologna in 1995.

Prof. Bachrach has conducted extensive research in the field of polyamines and studied various aspects of their development. He also was one of the founders of the Scientific Corps of the Israel Defense Forces in 1948, under the command of Prof. Ephraim Katzir, a former president of Israel.
-end-


The Hebrew University of Jerusalem

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.